Reconcile epithalon and epitalon spelling
FDA's safety discussion uses the name Epitalon and identifies aggregation and peptide-impurity concerns. Similar spelling is not a substitute for sequence-matched identity records.
Documentation to request
Request the sequence and analytical characterization, and separate longevity marketing from evidence for the actual proposed material.
Regulatory context: FDA: substance-specific safety concerns. Source reviewed . This source does not verify the identity, testing or availability of our catalog references.
Related guidance: Longevity clinic documentation questions. These references support a review, not a treatment recommendation or supply authorization.